Clinician-rated outcomes of patients with functional neurological disorders treated in an outpatient clinic.
W Curt LaFrance, Roberta Tedesco, Grayson L Baird...
https://pubmed.ncbi.nlm.nih.gov/36933399/Actively Recruiting
Led by Rhode Island Hospital · Updated on 2026-07-09
40
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating Neurobehavioral Therapy NBT as a treatment for motor functional neurological disorder mFND, also known as functional motor disorder. This pilot randomized clinical trial aims to determine if NBT can reduce mFND symptoms, lower common co-occurring symptoms, and improve overall functioning compared to standard medical care SMC. The study will enroll 40 adults aged 18 to 100 years diagnosed with mFND. Participants will be randomly assigned to one of two groups one group will receive 12 weekly individual NBT sessions over 12 to 18 weeks in addition to their usual medical care, while the other group will continue with their standard medical care without NBT. NBT sessions involve weekly one-hour appointments using a structured workbook, completed virtually with video appointments recorded for quality assurance. Both groups will attend five in-person clinic visits at baseline, 6 weeks, 12 weeks, 8 months, and 12 months. During these visits, participants will complete interviews and self-report surveys assessing functional status, quality of life, and mFND symptoms. Researchers will measure outcomes such as health-related quality of life and symptom severity using tools like the SF-36 Health Survey, Psychogenic Movement Disorders Rating Scale, and Simplified Functional Movement Disorders Rating Scale. Secondary assessments include anxiety, depression, trauma symptoms, and cognitive function. The study will monitor participants for up to 12 months to evaluate the therapys feasibility, acceptability, and preliminary effectiveness.
CONDITIONS
Pilot Neurobehavioral Therapy for Functional Neurological Disorder
A
Alexis Sr. Clinical Research Assistant
D
Deepica Clinical Research Program Coordinator
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Rhode Island Hospital
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Neuro-behavioral Therapy (NBT) | Standard Medical Care (SMC) |
|---|---|---|
| What it is | A manualized, multi‑modality, time‑limited whole‑person therapy delivered in one‑hour individual weekly sessions | Routine care including evaluation and follow‑up by neurology, physiatry, psychiatry, psychology, rehabilitation therapies and primary care |
| Role in the trial | Investigational therapy arm being evaluated for feasibility and impact on symptoms and functioning | Active comparator arm continuing routine clinical management |
| Primary use or purpose | Deliver structured psychotherapy to address motor functional neurological symptoms and associated quality of life | Continue usual multidisciplinary medical and rehabilitative care for mFND |
| How it is given or performed | Delivered as weekly one‑hour individual sessions over 12 to 18 weeks | Participants continue with routine care visits as arranged by their healthcare providers |
| Evidence maturity | Evidence under investigation in a pilot randomized trial | Psychotherapy and multidisciplinary care are recommended components in FND management guidelines and literature |
| Safety considerations | Not yet established | Not yet established |
| Important limitations | Pilot study with small sample size and single‑site design limits generalizability | Access to multidisciplinary psychotherapy varies and implementation outside specialized centers may be limited |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 to 18 weeks
Participants assigned to Neurobehavioral Therapy will attend weekly one-hour virtual sessions over 12 to 18 weeks using a structured workbook. Those assigned to standard medical care will continue their routine care with their clinicians without receiving NBT.
Weekly virtual therapy sessions for NBT group; routine care for standard medical care group
Duration - 12 months
All participants will attend five in-person clinic visits at baseline, 6 weeks, 12 weeks, 8 months, and 12 months to complete interviews and surveys assessing symptoms and quality of life.
Five in-person visits
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
W Curt LaFrance, Roberta Tedesco, Grayson L Baird...
https://pubmed.ncbi.nlm.nih.gov/36933399/Rhode Island Hospital
Lead Sponsor